$XENeutralMed

X-Energy Q1 Earnings Call Highlights

X-Energy reported Q1 operating expenses of $109.5 million, up 133% year over year, driven by higher ARDP activity, headcount, contractor costs and professional fees, plus a $100.8 million non-cash mark-to-market loss tied to a 2024 warrant. Net cash used in operating activities was $67.3 million. Liquidity totaled $944 million ($224 million cash; $450 million short-term; $270 million long-term). The company said it has no debt.

9/10
6/10
Med
Neutral
post-market / after-hours earnings-call recap for positioning ahead of upcoming regulatory milestones (Aug safety review; 4Q26 permit completion)
supports a cautious positive bias via project advancement, offset by higher operating expense and large non-cash warrant-related loss

Earnings-call updates emphasize advancing NRC reviews, fuel-facility construction, and a next 1-GW project target, while highlighting elevated non-cash warrant mark-to-market loss and rising operating expenses.

X-Energy reported Q1 liquidity/cash burn details and detailed regulatory milestones for the Dow Xe-100 deployment plus TX-1 fuel facility progress.

Near-term sentiment likely mixed: progress/risk-reduction from NRC and construction milestones may support, but higher opex and large non-cash mark-to-market loss could cap upside.

Background

The piece summarizes X-Energy’s Q1 earnings call, focusing on liquidity/cash burn, regulatory milestones for the Dow Seadrift Xe-100 deployment, and construction progress for the TX-1 advanced nuclear fuel fabrication facility.

Why it matters

Key near-term catalysts are regulatory schedule adherence (NRC draft safety evaluation milestone expected by August; Dow construction permit completion targeted for 4Q26) and operational readiness (TX-1 interior buildout starting 3Q26; operations expected 1H28). Financially, investors must parse elevated operating expenses and a large non-cash warrant mark-to-market loss versus strong liquidity.

Market relevance

Material for XE positioning because it combines fresh financial datapoints with concrete regulatory/construction timeline updates and a stated 2026 target for additional 1-GW project announcements.

Market effects

Reinforces advanced nuclear/SMR execution narrative (regulatory progress, fuel-fabrication licensing) that can influence sentiment across the nuclear development supply chain.

U.S. advanced nuclear momentum (Texas Seadrift and Oak Ridge fuel facility) may attract incremental attention from U.S. clean-energy and power-infrastructure investors.

U.K. Generic Design Assessment and HALEU supply discussions extend the read-through to European advanced nuclear commercialization timelines.

Alternative perspectives

Large opex growth and the $100.8M non-cash mark-to-market loss highlight financial volatility; progress milestones may not translate into near-term cash generation.

Customer balance-sheet risk transfer is emphasized, but the article provides no forward opex guidance; timing of next 1-GW project and final investment decisions could slip despite regulatory progress.

Key entities

  • X-Energy

    Advanced nuclear/SMR developer reporting Q1 operating expense growth, liquidity position, and execution milestones for Xe-100 and TX-1 fuel fabrication.

  • Dow

    Seadrift site partner for Xe-100 deployment; NRC environmental assessment completed ahead of schedule for its construction permit application.

  • NRC

    Completed environmental assessment and is progressing draft safety evaluation for Dow’s Xe-100 construction permit.

  • TX-1

    Oak Ridge fuel fabrication facility; ~56% vertical construction complete and licensed by NRC under Part 70.

  • Centrica

    UK commercial partnership for Xe-100 entering the Generic Design Assessment process.

Related articles

$XEMedAI 8/10

X-energy Reports First Quarter 2026 Results

X-energy (NASDAQ: XE) reported 1Q 2026 revenues and grant income of $43.4 million versus $20.8 million in 1Q 2025. The company said it raised about $1.1 billion in net IPO proceeds and began Nasdaq trading in April. It also cited NRC environmental clearance (FONSI) for Dow’s Seadrift project and a Part 70 fuel license for TRISO-X, plus UK GDA application and new SMR partner talks.

$XELow

2 New ‘Strong Buy’ IPO Stocks J.P. Morgan Is Bullish On

The article says IPO activity in the U.S. fell in 1Q26 to 32 IPOs from 63 in 1Q25, while proceeds rose to $11B from $9B. It highlights two JPMorgan “Strong Buy” IPO picks: X-Energy (XE), priced at $23 in an upsized April IPO raising about $1.02B, with JPMorgan’s Jeremy Tonet setting a $38 target; and HMH Holding (HMH), formed in 2021 and IPO’d in early April, initially priced at $20.

$CSCOMedAI 8/10

Analyst Upgrades Cisco Systems As It Anticipates $6 Billion in FY2027 AI Revenue

Cisco shares hit an all-time high after Q3 FY2026 results beat expectations, with adjusted EPS of $1.06 vs $1.04 and revenue of $15.84B vs $15.56B, up 12% year over year, supported by AI infrastructure and hyperscaler orders. Cisco expects AI infrastructure orders to reach $9B in FY2026 and FY2026 AI revenue of $4B. Analysts: HSBC raised CSCO to Buy with a $137 target (from $77) and BofA lifted its target to $135 (from $114), citing Q3 and Acacia demand. Cisco management expects about $6B in FY2